Advertisement
Screener

PLIANT THERAPEUTICS, INC. (PLRX) Cash Flow Breakdown

2.8 / 5 stars · 68/120 Roast Me

PLIANT THERAPEUTICS, INC. Cash Flow Breakdown

Cash flow breakdown shows where PLIANT THERAPEUTICS, INC.'s cash came from and where it went: from running the business, from investing (buying or selling equipment, companies and investments) and from financing (borrowing, paying back loans, buying back shares, paying dividends). One row per year or quarter. A minus sign means cash went out. Financing is shown line by line: buybacks, dividends, debt paid back, new debt and the rest. All amounts are the filed figures for that period.

  • Fiscal year ended 2025-12-31: from running the business, $128.34M went out.
  • Fiscal year ended 2025-12-31: from investing, $134.29M came in.
  • Fiscal year ended 2025-12-31: from financing, $31.70M went out.
  • Fiscal year ended 2025-12-31: change in cash, $25.74M went out.

A minus sign means cash went out. * = worked out from the filed year-to-date figures (hover to see how); greyed = already counted inside another line.

Each year (12 month)

Fiscal year endRunning the businessFrom investingDebt paid backNew debtNew shares soldNot split outChange in cash
2025-12-31-$128.34M$134.29M-$32.27M$0.00$570.00K*-$25.74M
2024-12-31-$155.50M$140.34M$0.00$19.91M$3.21M*$7.95M
2023-12-31-$116.36M-$127.01M$0.00$274.40M*$31.03M
2022-12-31-$94.63M-$150.20M$9.85M$217.00M*-$17.98M
2021-12-31-$75.44M$73.70M$0.00$2.98M$783.00K
2020-12-31-$37.27M-$210.87M$442.00K$212.77M*-$34.92M
2019-12-31-$2.75M-$17.93M$174.00K$45.37M*$24.86M

Each quarter (3 month)

Quarter endRunning the businessFrom investingNew debtNew shares soldNot split outChange in cash
2026-06-30-$12.80M*$15.49M*
2026-03-31-$19.23M-$4.10M-$23.25M
2025-12-31-$17.79M*$1.77M*$0.00*-$32.27M*
2025-09-30-$21.08M*$27.92M*$0.00*
2025-06-30-$40.60M*$35.49M*$0.00*
2025-03-31-$48.86M$69.11M$0.00$20.75M
2024-12-31-$47.66M*$39.13M*$1.00K*
2024-09-30-$32.27M*$30.96M*$0.00*$543.00K*
2024-06-30-$45.30M*$10.70M*$0.00*$684.00K*
2024-03-31-$30.27M$59.55M$19.91M$1.88M*$51.06M
2023-12-31-$25.10M*$31.92M*$0.00*
2023-09-30-$36.22M*$38.25M*$0.00*$699.00K*
2023-06-30-$24.76M*-$22.98M*$0.00*
2023-03-31-$30.28M-$174.21M$0.00$273.33M*$68.84M
2022-12-31-$31.24M*$20.02M*-$150.00K*
2022-09-30-$18.50M*-$178.25M*$0.00*$216.30M*
2022-06-30-$24.40M*$6.50M*$447.00K*$9.98M*
2022-03-31-$20.50M$1.53M-$19.12M
2021-12-31-$19.86M*$25.78M*$0.00*$516.00K*
2021-09-30-$22.51M*$32.10M*$0.00*
2021-06-30-$19.40M*$3.58M*$371.00K*
2021-03-31-$13.66M$12.23M$1.37M-$63.00K
2020-12-31-$16.48M*$11.91M*$237.00K*
2020-09-30-$15.79M*-$105.08M*$3.00K*-$2.37M*
2020-06-30$7.77M*-$106.32M*$176.00K*$163.46M*
2020-03-31-$12.77M-$11.37M$26.00K$51.67M*$27.56M
2019-12-31$36.74M*-$9.18M*$46.83M*
2019-09-30-$14.88M*$13.75M*$14.00K*

Similar stocks

Stock NameCountryMarket CapPE Ratio
TENAX THERAPEUTICS, INC. (TENX)United States$0.071B-7.17
PMV Pharmaceuticals, Inc. (PMVP)United States$0.071B-0.95
Yarrow Bioscience, Inc. (YARW)United States$0.070B
Lunai Bioworks Inc. (LNAI)United States$0.072B-0.11
Spero Therapeutics, Inc. (SPRO)United States$0.073B17.41
Connect Biopharma Holdings Ltd (CNTB)$0.069B-2.17
Cingulate Inc. (CING)United States$0.073B-2.64
Aldeyra Therapeutics, Inc. (ALDX)United States$0.074B-5.57
XBiotech Inc. (XBIT)United States$0.066B-1.56
OS Therapies Inc (OSTX)United States$0.076B-2.17